IL2 and cancer: Multiple cancer types exhibited significant positive association of CD36 in multiple immune and inflammation-related pathways, including IL2/STAT5 signaling, IL6/JAK/STAT3 signaling, TNFα/NF-kB signaling, inflammatory response, interferonγ response, EMT, complement, apoptosis, allograft rejection and adipogenesis (Fig. 3A).